Welcome to LookChem.com Sign In|Join Free

CAS

  • or

122839-50-3

Post Buying Request

122839-50-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

122839-50-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 122839-50-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,2,8,3 and 9 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 122839-50:
(8*1)+(7*2)+(6*2)+(5*8)+(4*3)+(3*9)+(2*5)+(1*0)=123
123 % 10 = 3
So 122839-50-3 is a valid CAS Registry Number.

122839-50-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-Trifluoromethyl-L-phenylalaninehydrochloride

1.2 Other means of identification

Product number -
Other names 4-TRIFLUOROMETHYL-L-PHENYLALANINE HYDROCHLORIDE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:122839-50-3 SDS

122839-50-3Relevant articles and documents

SUBSTITUTED PROPANAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME

-

Page/Page column 122, (2008/06/13)

It is an object of the present invention to provide a substituted propanamide derivative or a pharmacologically acceptable salt thereof that is useful as a prophylactic or therapeutic agent for a bone metabolic disease. The present invention relates to a pharmaceutical composition comprising a compound having General Formula (I) or a pharmacologically acceptable salt thereof as an active ingredient: [wherein, R1 represents a C6-C10 aryl group that may be substituted by a group selected from Substituent Group α, for example; R2 represents a C6-C10aryl group that may be substituted by a group selected from Substituent Group α, for example; and X represents a hydroxyl group or a C1-C6 alkoxy group, for example].

Synthesis and biological activity of some very hydrophobic superagonist analogues of luteinizing hormone-releasing hormone

Nestor Jr.,Ho,Simpson,Horner,Jones,McRae,Vickery

, p. 795 - 801 (2007/10/02)

-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 122839-50-3